Target Price | $35.50 |
Price | $22.23 |
Potential |
59.69%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target vTv Therapeutics, Inc. Class A 2026 .
The average vTv Therapeutics, Inc. Class A target price is $35.50.
This is
59.69%
register free of charge
$36.00
61.94%
register free of charge
$35.00
57.44%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend vTv Therapeutics, Inc. Class A to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the vTv Therapeutics, Inc. Class A stock has an average upside potential 2026 of
59.69%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.20 | -3.97 |
67.04% | 24.06% | |
P/E | negative |
1 Analysts have issued a vTv Therapeutics, Inc. Class A forecast for earnings per share. The average vTv Therapeutics, Inc. Class A EPS is
This results in the following potential growth metrics and future valuations:
vTv Therapeutics, Inc. Class A...
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
Alliance Global Partners |
Locked
➜
Locked
|
Locked | Dec 09 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 09 2025 |
Locked
Alliance Global Partners:
Locked
➜
Locked
|
Dec 09 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.